Difficulty: Medium
Average Score: 66%
Practice
A 55-year-old female with type 2 diabetes is prescribed canagliflozin. Canagliflozin works by:
Correct answer
A
Rationale
The correct answer is A: Inhibiting the reabsorption of glucose in the kidneys. Canagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that works by blocking the reabsorption of glucose in the kidneys, leading to increased urinary glucose excretion and lowering blood glucose levels. This mechanism of action is unique to SGLT2 inhibitors and helps improve glycemic control in patients with type 2 diabetes.
Choice B is incorrect because canagliflozin does not stimulate the pancreas to release more insulin. Choice C is incorrect as canagliflozin does not increase the release of glucagon from the pancreas. Choice D is incorrect because canagliflozin does not directly improve insulin sensitivity in peripheral tissues. The key mechanism of action of canagliflozin lies in its specific inhibition of glucose reabsorption in the kidneys, making choice A the correct answer.
Choice B is incorrect because canagliflozin does not stimulate the pancreas to release more insulin. Choice C is incorrect as canagliflozin does not increase the release of glucagon from the pancreas. Choice D is incorrect because canagliflozin does not directly improve insulin sensitivity in peripheral tissues. The key mechanism of action of canagliflozin lies in its specific inhibition of glucose reabsorption in the kidneys, making choice A the correct answer.